Passage Bio, Inc. (PASG) Tops Q4 EPS by 2c
Passage Bio, Inc. (NASDAQ: PASG) reported Q4 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Passage Bio, Inc. (NASDAQ: PASG) reported Q4 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.